{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Protéine G cdc42 : Questions médicales les plus fréquentes",
"headline": "Protéine G cdc42 : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Protéine G cdc42 : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-21",
"dateModified": "2025-02-15",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Protéine G cdc42"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Protéines G rho",
"url": "https://questionsmedicales.fr/mesh/D020741",
"about": {
"@type": "MedicalCondition",
"name": "Protéines G rho",
"code": {
"@type": "MedicalCode",
"code": "D020741",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.476.338.400.700"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Protéine G cdc42",
"alternateName": "cdc42 GTP-Binding Protein",
"code": {
"@type": "MedicalCode",
"code": "D020764",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Jeong Woo Park",
"url": "https://questionsmedicales.fr/author/Jeong%20Woo%20Park",
"affiliation": {
"@type": "Organization",
"name": "Department of Biological Science, University of Ulsan, Ulsan, 44610, South Korea."
}
},
{
"@type": "Person",
"name": "Ming Huang",
"url": "https://questionsmedicales.fr/author/Ming%20Huang",
"affiliation": {
"@type": "Organization",
"name": "Environmental Toxicology Graduate Program, University of California, Riverside, Riverside, California 92521, United States."
}
},
{
"@type": "Person",
"name": "Yinsheng Wang",
"url": "https://questionsmedicales.fr/author/Yinsheng%20Wang",
"affiliation": {
"@type": "Organization",
"name": "Department of Chemistry, University of California, Riverside, Riverside, California 92521, United States."
}
},
{
"@type": "Person",
"name": "Natsumi Maruta",
"url": "https://questionsmedicales.fr/author/Natsumi%20Maruta",
"affiliation": {
"@type": "Organization",
"name": "Plant Genetic Engineering Laboratory, School of Agriculture and Food Sciences, University of Queensland, Brisbane, QLD, 4072, Australia."
}
},
{
"@type": "Person",
"name": "Yuri Trusov",
"url": "https://questionsmedicales.fr/author/Yuri%20Trusov",
"affiliation": {
"@type": "Organization",
"name": "Plant Genetic Engineering Laboratory, School of Agriculture and Food Sciences, University of Queensland, Brisbane, QLD, 4072, Australia."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "The development of a novel Orthodontic Alignment Index and its use to evaluate the effect of residual overjet on the stability of the alignment of the maxillary anterior dentition.",
"datePublished": "2022-12-28",
"url": "https://questionsmedicales.fr/article/36575336",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s40510-022-00444-1"
}
},
{
"@type": "ScholarlyArticle",
"name": "Long term stability of a high-angle skeletal Class II open bite treated with high-pull headgear and modified transpalatal arch: A case report.",
"datePublished": "2022-12-13",
"url": "https://questionsmedicales.fr/article/36521308",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.ortho.2022.100717"
}
},
{
"@type": "ScholarlyArticle",
"name": "Are morphological and morphometric characteristics of maxillary anterior region and nasopalatine canal related to each other?",
"datePublished": "2022-08-08",
"url": "https://questionsmedicales.fr/article/35941313",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s11282-022-00647-6"
}
},
{
"@type": "ScholarlyArticle",
"name": "Malocclusion complexity and orthodontic treatment need in children with autism spectrum disorder.",
"datePublished": "2022-06-15",
"url": "https://questionsmedicales.fr/article/35701552",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00784-022-04578-8"
}
},
{
"@type": "ScholarlyArticle",
"name": "Dental manifestation and management in a patient with combined pituitary hormone deficiency: a two-year case report.",
"datePublished": "2023-09-03",
"url": "https://questionsmedicales.fr/article/37732453",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.22514/jocpd.2023.069"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Acides aminés, peptides et protéines",
"item": "https://questionsmedicales.fr/mesh/D000602"
},
{
"@type": "ListItem",
"position": 3,
"name": "Protéines",
"item": "https://questionsmedicales.fr/mesh/D011506"
},
{
"@type": "ListItem",
"position": 4,
"name": "Protéines et peptides de signalisation intracellulaire",
"item": "https://questionsmedicales.fr/mesh/D047908"
},
{
"@type": "ListItem",
"position": 5,
"name": "Protéines G",
"item": "https://questionsmedicales.fr/mesh/D019204"
},
{
"@type": "ListItem",
"position": 6,
"name": "Protéines G monomériques",
"item": "https://questionsmedicales.fr/mesh/D020559"
},
{
"@type": "ListItem",
"position": 7,
"name": "Protéines G rho",
"item": "https://questionsmedicales.fr/mesh/D020741"
},
{
"@type": "ListItem",
"position": 8,
"name": "Protéine G cdc42",
"item": "https://questionsmedicales.fr/mesh/D020764"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Protéine G cdc42 - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Protéine G cdc42",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-13",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Protéine G cdc42",
"description": "Comment diagnostiquer une dysfonction de cdc42 ?\nQuels tests sont utilisés pour cdc42 ?\nY a-t-il des biomarqueurs pour cdc42 ?\nQuels symptômes indiquent un problème avec cdc42 ?\nPeut-on détecter cdc42 dans des échantillons biologiques ?",
"url": "https://questionsmedicales.fr/mesh/D020764?mesh_terms=Overbite&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Protéine G cdc42",
"description": "Quels sont les symptômes d'une mutation de cdc42 ?\nComment cdc42 affecte-t-il la cellule ?\nY a-t-il des signes cliniques associés à cdc42 ?\nCdc42 est-il lié à des maladies spécifiques ?\nQuels effets cdc42 a-t-il sur le cytosquelette ?",
"url": "https://questionsmedicales.fr/mesh/D020764?mesh_terms=Overbite&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Protéine G cdc42",
"description": "Peut-on prévenir les mutations de cdc42 ?\nY a-t-il des mesures préventives pour les maladies liées à cdc42 ?\nComment le mode de vie influence-t-il cdc42 ?\nLes tests génétiques peuvent-ils prévenir des problèmes avec cdc42 ?\nY a-t-il des recommandations diététiques pour cdc42 ?",
"url": "https://questionsmedicales.fr/mesh/D020764?mesh_terms=Overbite&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Protéine G cdc42",
"description": "Quels traitements ciblent cdc42 ?\nPeut-on utiliser des thérapies géniques pour cdc42 ?\nY a-t-il des médicaments pour moduler cdc42 ?\nComment la recherche avance-t-elle sur cdc42 ?\nLes traitements sont-ils efficaces contre cdc42 ?",
"url": "https://questionsmedicales.fr/mesh/D020764?mesh_terms=Overbite&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Protéine G cdc42",
"description": "Quelles complications sont liées à cdc42 ?\nCdc42 peut-il entraîner des problèmes neurologiques ?\nY a-t-il des complications à long terme avec cdc42 ?\nComment cdc42 affecte-t-il le système immunitaire ?\nLes complications de cdc42 sont-elles réversibles ?",
"url": "https://questionsmedicales.fr/mesh/D020764?mesh_terms=Overbite&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Protéine G cdc42",
"description": "Quels sont les facteurs de risque pour cdc42 ?\nL'exposition à des toxines affecte-t-elle cdc42 ?\nLes antécédents familiaux augmentent-ils le risque ?\nLe stress peut-il affecter cdc42 ?\nY a-t-il des groupes à risque pour cdc42 ?",
"url": "https://questionsmedicales.fr/mesh/D020764?mesh_terms=Overbite&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une dysfonction de cdc42 ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests génétiques et des analyses de signalisation cellulaire peuvent être utilisés."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour cdc42 ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests incluent l'immunoblotting et la microscopie à fluorescence."
}
},
{
"@type": "Question",
"name": "Y a-t-il des biomarqueurs pour cdc42 ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Actuellement, il n'existe pas de biomarqueurs spécifiques pour cdc42."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent un problème avec cdc42 ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des anomalies dans la migration cellulaire et la morphogenèse peuvent être observées."
}
},
{
"@type": "Question",
"name": "Peut-on détecter cdc42 dans des échantillons biologiques ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, cdc42 peut être détecté dans des échantillons de tissus ou de cellules."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une mutation de cdc42 ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les mutations peuvent entraîner des troubles de la migration cellulaire et des malformations."
}
},
{
"@type": "Question",
"name": "Comment cdc42 affecte-t-il la cellule ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Cdc42 régule la forme et le mouvement des cellules, influençant leur fonction."
}
},
{
"@type": "Question",
"name": "Y a-t-il des signes cliniques associés à cdc42 ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des anomalies dans le développement et la motilité cellulaire peuvent être observées."
}
},
{
"@type": "Question",
"name": "Cdc42 est-il lié à des maladies spécifiques ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des anomalies de cdc42 sont associées à des cancers et des maladies génétiques."
}
},
{
"@type": "Question",
"name": "Quels effets cdc42 a-t-il sur le cytosquelette ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Cdc42 joue un rôle clé dans la régulation du cytosquelette, influençant la forme cellulaire."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les mutations de cdc42 ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention des mutations génétiques est complexe et dépend de facteurs environnementaux."
}
},
{
"@type": "Question",
"name": "Y a-t-il des mesures préventives pour les maladies liées à cdc42 ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des conseils génétiques peuvent aider à évaluer le risque de maladies liées à cdc42."
}
},
{
"@type": "Question",
"name": "Comment le mode de vie influence-t-il cdc42 ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un mode de vie sain peut réduire le risque de maladies associées à cdc42."
}
},
{
"@type": "Question",
"name": "Les tests génétiques peuvent-ils prévenir des problèmes avec cdc42 ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les tests génétiques peuvent identifier les porteurs de mutations de cdc42."
}
},
{
"@type": "Question",
"name": "Y a-t-il des recommandations diététiques pour cdc42 ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée peut soutenir la santé cellulaire, mais n'affecte pas directement cdc42."
}
},
{
"@type": "Question",
"name": "Quels traitements ciblent cdc42 ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des inhibiteurs spécifiques de cdc42 sont en cours de développement pour le cancer."
}
},
{
"@type": "Question",
"name": "Peut-on utiliser des thérapies géniques pour cdc42 ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "La thérapie génique est une approche potentielle pour corriger les mutations de cdc42."
}
},
{
"@type": "Question",
"name": "Y a-t-il des médicaments pour moduler cdc42 ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des composés chimiques sont en cours d'évaluation pour moduler l'activité de cdc42."
}
},
{
"@type": "Question",
"name": "Comment la recherche avance-t-elle sur cdc42 ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "La recherche se concentre sur les inhibiteurs et les voies de signalisation associées."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils efficaces contre cdc42 ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'efficacité des traitements dépend du type de maladie et de la mutation spécifique."
}
},
{
"@type": "Question",
"name": "Quelles complications sont liées à cdc42 ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des troubles du développement et des cancers."
}
},
{
"@type": "Question",
"name": "Cdc42 peut-il entraîner des problèmes neurologiques ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des anomalies de cdc42 sont associées à des troubles neurologiques dans certains cas."
}
},
{
"@type": "Question",
"name": "Y a-t-il des complications à long terme avec cdc42 ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications à long terme peuvent inclure des cancers et des malformations congénitales."
}
},
{
"@type": "Question",
"name": "Comment cdc42 affecte-t-il le système immunitaire ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Cdc42 peut influencer la réponse immunitaire, mais les effets varient selon les contextes."
}
},
{
"@type": "Question",
"name": "Les complications de cdc42 sont-elles réversibles ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être gérées, mais d'autres peuvent être permanentes."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour cdc42 ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent des prédispositions génétiques et des influences environnementales."
}
},
{
"@type": "Question",
"name": "L'exposition à des toxines affecte-t-elle cdc42 ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines toxines environnementales peuvent influencer l'expression de cdc42."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux augmentent-ils le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux de maladies génétiques peuvent augmenter le risque."
}
},
{
"@type": "Question",
"name": "Le stress peut-il affecter cdc42 ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le stress peut influencer la signalisation cellulaire, y compris celle de cdc42."
}
},
{
"@type": "Question",
"name": "Y a-t-il des groupes à risque pour cdc42 ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les individus avec des mutations génétiques spécifiques sont à risque accru."
}
}
]
}
]
}
It is thought that achieving a normal overjet may help to stabilise the alignment of the maxillary anterior dentition. Little's Irregularity Index is limited in assessing discrete post-orthodontic cha...
To compare the post-treatment stability of maxillary anterior dental alignment in subjects treated either to a Class I incisor relationship or an increased overjet (> 4 mm) following fixed appliance-b...
The Orthodontic Alignment Index (OAI) was developed and validated using a panel of 63 raters. The new index accounts for a range of weighted features including contact point displacement, spacing, rec...
Eighty-two participants were included with a positive correlation observed between LII and OAI at the 12-month post-treatment review with a 1-mm increase in LII associated with a 2-point increase in t...
Using a novel index (OAI) and LII, there was limited post-treatment relapse in alignment of the maxillary anterior dentition over a 12-month period. Based on this retrospective evaluation, achieving a...
This case report describes the treatment of an adolescent patient with an Angle Class II malocclusion, severe open bite and overjet, proclined incisors, skeletal Class II anteroposterior dysplasia, hi...
The main purpose of this article was to clarify the relationship of anterior bone and tooth morphology with NPC. The anatomical features of the NPC region in three dimensions from coronal, axial, and ...
In this retrospective study, CBCTs of a total of 330 individuals between the ages of 17 and 82 were evaluated. The effects of SRP, AOD, CI/PP angle, NPC/PP angle and CA on the anatomical features of N...
While the SRPs, CI/PP angle, NPC/PP angle, CA, and age did not differ statistically according to NPC shape (p > 0.05), NPC shape varied according to gender and AOD (p < 0.05). It was found that cylind...
The results showed that gender and AOD are influential factors on NPC shape. While conical-shaped NPC is more common in individuals with bite depth incisal, cylindrical-shaped NPC is more likely to be...
This study aimed to investigate the malocclusion complexity and orthodontic treatment need among children with and without autism spectrum disorder (ASD) referred for orthodontic treatment by quantify...
Dental records of 48 ASD and 49 non-ASD consecutive patients aged between 9 and 18 years (median age 13.0 years) referred for orthodontic treatment were reviewed and compared. The Discrepancy Index (D...
The results show that both malocclusion complexity (DI, p = 0.0010) and orthodontic treatment need (IOTN-DHC, p = 0.0025; IOTN-AC p = 0.0009) were significantly higher in children with ASD. Furthermor...
Malocclusion complexity and orthodontic treatment need are statistically significantly higher among children with ASD than children without ASD, independent of age and sex....
Children with autism may benefit from visits to a dental specialist (orthodontist) to prevent, to some extent, developing malocclusions from an early age....
Combined pituitary hormone deficiency (CPHD) is a rare disorder caused by a complete absence of the anterior pituitary gland hormones. The Dental manifestation, managmnet and two-year-follow-up of a c...
Anterior repositioning splint (ARS) is used to treat temporomandibular joint (TMJ) disc displacement with reduction (DDwR). However, high recurrence rate remains a problem especially in patients with ...
This study optimised standard ARS therapy and proposed a step-back ARS retraction (SAR) method in adult patients with DDwR....
Dental examinations and magnetic resonance imaging of TMJ were obtained before treatment (T0), 1 to 3 months (T1), 3 to 6 months (T2) and 6 to 12 months (T3) during treatment in 48 adults (average age...
The maximum interincisal opening was increased from 44.3 ± 6.9 to 45.3 ± 6.3 mm (p < .01), and joint pain was alleviated after ARS treatment. The overall success rate of ARS wearing was 92.1% (58/63) ...
ARS treatment could improve mouth opening and joint symptoms in adult DDwR patients. SAR method was suitable for treating DDwR patients with deep overbite and overjet and improved retrodiscal tissue a...
Clear aligners are reported to control anterior open bites. Despite this, anterior extrusion remains difficult with aligners. Optimized extrusion attachments on incisors may facilitate anterior extrus...
This was a retrospective cohort study. The pre- and post-treatment intraoral scans of patients with anterior open bite treated with Invisalign aligners were assessed. Patients were divided into two gr...
A total of 86 patients were included. Both groups showed significant increases in overbite, but there was no difference in the open bite correction efficacy in patients with conventional versus optimi...
Anterior open bite can be corrected regardless of the attachment type. Optimized attachments are no more effective than using conventional attachments in incisor extrusion to correct open bite. Patien...
In an ideal clinical setting, orthodontic therapy with clear aligners (CA) should improve the patients' initial malocclusion and must guarantee equivalence between the results predicted and those obta...
A systematic computerized search was performed in 3 databases: PubMed, Scopus, and Embase. Inclusion criteria selected observational and clinical studies performed in at least 10 adult orthodontic pat...
The 3 database computerized searches resulted in 1,553 articles, and 169 full texts were considered potentially relevant. After applying the eligibility criteria, 33 studies were included. Most studie...
The studies have demonstrated improvement of initial malocclusion through CA treatments. Still, predictability degree is overestimated and does not accurately reflect the occlusion immediately at the ...
Dental trauma is a highly prevalent dental emergency. Children and adolescents without inadequate lip coverage, increased overjet, and anterior open bite are associated with the occurrence of traumati...
Studies included in the qualitative synthesis of a recently published comprehensive systematic review and meta-analysis on the topic were screened. Studies that only mentioned the performance of bivar...
Fifty-five observational studies were screened, of which 11 were excluded due to the mention of only bivariate analyzes or the lack of multivariate analyses. The remaining 44 studies were critically a...
Most studies did not acknowledge the control for possible confounding factors and rarely stressed the need for caution in interpreting their results. Cross-sectional studies do not allow inferring a c...
The objective of this study was to compare the long-term cephalometric stability after successful therapy of nonextraction Class II malocclusion with elastics and with headgear....
The sample comprised 43 patients with Class II malocclusion and was divided into 2 groups. The elastic group (EG) consisted of 20 patients treated with fixed appliances associated with Class II elasti...
The groups were matched regarding initial age, time of long-term posttreatment evaluation, initial malocclusion severity, quality of treatment result, and all pretreatment cephalometric variables. Int...
Nonextraction Class II malocclusion treatment with elastics or extraoral headgear have similar long-term posttreatment stability....